Regulatory News

News Print
Midkine Antibody Program - Festival of Biologics Download
ROQ Presents Study Results at the ESGCT Conference Download
Director/PDMR Shareholding Download
Director/PDMR Shareholding Download
Interim Results to 30 June 2022 Download
Investor Presentation Download
Board and Management Appointments Download
Acquisition Completion, Admission & Voting Rights Download
Notice of Admission Download
Publication of Prospectus Download
Pre-clinical Program & Transaction Update Download
Appointment of Joint Broker Download
Commencement of Trading on US OTCQB Venture Market Download
Director/PDMR Shareholding Download
Director/PDMR Shareholding Download
Result of AGM Download
Update on Acquisition of Oncogeni and Placing Download
Issue of Warrants Download
Investor Presentation Download
Second Price Monitoring Extn Download
Price Monitoring Extension Download
Proposed Acquisition of Oncogeni Limited & Placing Download
Notice of AGM - Correction Download
Notice of AGM Download
Pre-clinical Update Download
Annual Report & Financial Statements Download
Non-Executive Director Appointment Download
Board Appointment Download
Holding(s) in Company Download
Investor Presentation Download
Patent Filed – New Drug Class Targeting Midkine Download
Holding(s) in Company Download
Appointment of Strategic & Scientific Advisor Download
Holding(s) in Company Download
Holding(s) in Company Download
Director/PDMR Shareholding Download
Holding(s) in Company Download
Price Monitoring Extension Download
Holding(s) in Company Download
Holding(s) in Company Download
Pre-clinical Update Download
Publication of New Research Download
Change of Company Name Download
Holding(s) in Company Download
Second Price Monitoring Extn Download
Price Monitoring Extension Download
Acquisition Completion, Admission & Voting Rights Download
Publication of Prospectus Download
Results of General Meeting Download
Conditional Placing to Raise £3 Million Download